Failure of Erythromycin Estolate Therapy in In Utero Syphilis
- 5 October 1964
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 190 (1) , 70-71
- https://doi.org/10.1001/jama.1964.03070140076020
Abstract
ERYTHROMYCIN is the most frequently administered antibiotic for the treatment of syphilis in patients with known penicillin allergy. Studies leading to current recommendations of optimum dosages of this drug in various stages of syphilis have been conducted in the Houston Social Hygiene Clinic, but its use during pregnancy has not yet been adequately evaluated. The observation of one patient in our study, who had a good serologic response to treatment with 15 gm of erythromycin estolate (Ilosone), but bore an infant who died of congenital syphilis, is the subject of this report. Report of a Case The mother, 16 years of age, gravida II, para I, in approximately the sixth month of pregnancy, had a perigenital, palmar, and plantar maculopapular rash. The clinical diagnosis, secondary syphilis, was supported by a Venereal Disease Research Laboratories slide test (flocculation test using the Atlantic VDRL's specific antigen) reactive at 64 dilutions. Because ofKeywords
This publication has 4 references indexed in Scilit:
- Oral Propionyl Erythromycin in Treating Early SyphilisPublic Health Reports®, 1963
- Oral Erythromycin in the Treatment of Early Syphilis**From the Department of Dermatology and Syphilology, Baylor University College of Medicine, Houston, Texas.Supported by Grants from Abbott Laboratories, North Chicago, Illinois, and Eli Lilly and Company, Indianapolis, Indiana.Journal of Investigative Dermatology, 1962
- Erythromycin in Treatment of Early SyphilisArchives of internal medicine (1960), 1961
- SOME LABORATORY AND CLINICAL OBSERVATIONS ON A NEW ANTIBIOTIC, ERYTHROMYCIN (ILOTYCIN)1952